Violation Tracker Parent Company Summary
|Top 5 Offense Groups (Groups Defined)||Penalty Total||Number of Records|
|Top 5 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$501,638,250||5|
|kickbacks and bribery||$390,000,000||2|
|price-fixing or anti-competitive practices||$215,350,000||3|
|False Claims Act and related||$99,474,307||10|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
CHIRON; CIBA Vision; Eon Labs Inc.; Geneva Pharmaceuticals; NOVARTIS; Novartis Corporation; Novartis Corporation and Alcon Laboratories; NOVARTIS VACCINES AND DIAGNOSTICS AND NOVARTIS PHARMACEUTICALS; Sandoz
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||FDA||$422,500,000|
|Novartis Pharmaceuticals||kickbacks and bribery||2015||USAO||$390,000,000|
|Sandoz Inc.||price-fixing or anti-competitive practices||2020||DOJ_ANTITRUST||$195,000,000|
|Novartis Corporation||employment discrimination||2010||private lawsuit-federal||$175,000,000|
|Novartis||wage and hour violation||2012||private lawsuit-federal||$99,000,000|
|Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||MULTI-AG||(*) $88,258,694|
|Novartis Pharmaceuticals Corporation||kickbacks and bribery||2015||MULTI-AG||(*) $83,129,754|
|Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||FDA||$72,500,000|
|Sandoz, Inc.||False Claims Act and related||2011||MS-AG||$30,110,618|
|Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||MULTI-AG||(*) $29,000,000|
|Novartis AG||Foreign Corrupt Practices Act||2016||SEC||$25,000,000|
|Novartis Pharmaceuticals||False Claims Act and related||2019||IL-AG||$21,280,356|
|Sandoz||False Claims Act and related||2009||KY-AG||$16,000,000|
|Geneva Pharmaceuticals||price-fixing or anti-competitive practices||2005||MULTI-AG||$15,350,000|
|Sandoz||False Claims Act and related||2013||LA-AG||$13,100,000|
|Sandoz, Inc.||HHS civil monetary penalties||2015||HHSOIG||$12,640,000|
|Novartis Corporation and Alcon Laboratories||employment discrimination||2016||private lawsuit-federal||$8,000,000|
|Novartis||False Claims Act and related||2013||LA-AG||$7,000,000|
|Novartis Pharmaceuticals||off-label or unapproved promotion of medical products||2012||TX-AG||$6,638,250|
|CIBA Vision||price-fixing or anti-competitive practices||2000||MULTI-AG||$5,000,000|
|Eon Labs Inc.||False Claims Act and related||2010||DOJ_CIVIL||$3,500,000|
|Novartis Pharmaceuticals Corporation||False Claims Act and related||2010||HI-AG||$3,333,333|
|Novartis Pharmaceuticals Corp.||False Claims Act and related||2012||KY-AG||$2,750,000|
|Sandoz Inc.||False Claims Act and related||2010||ID-AG||$1,650,000|
|Novartis Pharmaceuticals Corp.||False Claims Act and related||2013||ID-AG||$750,000|
|Sandoz, Inc.||HHS civil monetary penalties||2011||HHSOIG||$230,000|
|Chiron Corporation Ltd||economic sanction violation||2004||OFAC||$168,500|
|CHIRON CORPORATION||workplace safety or health violation||2000||OSHA||$90,140|
|Novartis Pharmaceuticals||employment discrimination||2013||OFCCP||$51,594|
|NOVARTIS PRODUCTS||environmental violation||2000||EPA||$13,200|
|NOVARTIS PHARMACEUTICALS CORPORATION||benefit plan administrator violation||2006||EBSA||$10,001|
|Novartis Animal Health US, Inc.||environmental violation||2006||EPA||$6,500|
|NOVARTIS CONSUMER HEALTH INC.||workplace safety or health violation||2013||OSHA||$6,078|
|NOVARTIS CONSUMER HEALTH, INC.||environmental violation||2000||EPA||$5,000|